IBEX Grant of Options

(firmenpresse) - MONTREAL, QUEBEC -- (Marketwired) -- 07/03/13 -- IBEX Technologies Inc. (TSX VENTURE: IBT) today announces the grant of options to Richard Collin, CPA, CA, its newly appointed Director of Finance.

In connection with his appointment, Mr. Collin has been granted options to acquire up to 50,000 common shares of IBEX at an exercise price of $0.08 per common share for a term of 10 years pursuant to IBEX's incentive stock option plan.

ABOUT IBEX

The Company, through its wholly owned subsidiaries, IBEX Pharmaceuticals Inc. (Montreal, QC) and Bio-Research Products Inc. (North Liberty, IA), manufactures and markets enzymes for biomedical use. IBEX also manufactures and markets a series of arthritis assays which are widely used in osteoarthritis research.

For more information, please visit the Company's website at .

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



Contacts:
IBEX Technologies Inc.
Paul Baehr
President & CEO
514-344-4004 x 143

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 03.07.2013 - 18:50 Uhr
Sprache: Deutsch
News-ID 275559
Anzahl Zeichen: 0

contact information:
Town:

MONTREAL, QUEBEC

Kategorie:

Biotech

Diese Pressemitteilung wurde bisher 258 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"IBEX Grant of Options"
steht unter der journalistisch-redaktionellen Verantwortung von

IBEX Technologies Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

IBEX Reports Change in Board Composition ...

MONTREAL, QUEBEC -- (Marketwired) -- 07/13/17 -- IBEX Technologies Inc. ("IBEX" or the "Company") (TSX VENTURE: IBT) today reported the death of Bernard Patriacca, a long-serving board member and Chairman of its Audit Committee. ...

IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2 ...

MONTREAL, QUEBEC -- (Marketwired) -- 06/19/17 -- IBEX Technologies Inc. ("IBEX" or the "Company") (TSX VENTURE: IBT) today reported its financial results for the nine months ended April 30, 2017."As expected, sales and net ...

IBEX announces stock option grant to directors and officers ...

MONTREAL, QUEBEC -- (Marketwired) -- 04/24/17 -- IBEX Technologies Inc. ("IBEX" or the "Company") (TSX VENTURE: IBT) today announced that on April 21, 2017 the Company's Board of Directors granted stock options representing ...

Alle Meldungen von IBEX Technologies Inc.